ACAnu V. Chandran

Anu V. Chandran

*This is an algorithmically generated author record based on publicly available information.

Anu V. Chandran has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dengue virus NS5 RdRp protease binding assay for compound screening using grating-coupled interferometry v1

    by Eda Capkin, Korvus Wang, Michael Fairhead, Milo Cooper, Mathew Golding, Tracy Keates, Charlotte Chinn, Peter Marples, Ali Ebrahim, Anu V. Chandran, et al.

    This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against Dengue virus (DENV) NS5 RdRp protease using the Creoptix Wave system. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged DENV NS5 RdRp protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).

  • Open Access

    Zika virus NS5 RdRp protease binding assay for compound screening using grating-coupled interferometry v1

    by Eda Capkin, Korvus Wang, Michael Fairhead, Milo Cooper, Mathew Golding, Tracy Keates, Charlotte Chinn, Peter Marples, Ali Ebrahim, Anu V. Chandran, et al.

    This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against Zika virus (ZIKV) NS5 RdRp protease using the Creoptix Wave system. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged ZIKV NS5 RdRp protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).

  • Open Access

    Coxsackievirus A16 2A protease binding assay for compound screening using grating-coupled interferometry v2

    by Eda Capkin, Korvus Wang, Michael Fairhead, Milo Cooper, Mathew Golding, Tracy Keates, Charlotte Chinn, Peter Marples, Ali Ebrahim, Anu V. Chandran, et al.

    This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against coxsackievirus A16 (CVA16) 2A protease using the Creoptix Wave system. CVA16 2A protease is used as a surrogate for the related enterovirus A71 (EV-A71) 2A protease in the pan-enteroviral drug discovery efforts by our collaborator, the AI-Driven Structure-Enabled Antiviral Platform (ASAP) Discovery Center, and was chosen as the target for OpenBind's first data release package. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged CVA16 2A protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).

  • Open Access

    Zika virus NS2B-NS3 protease binding assay for compound screening using grating-coupled interferometry v1

    by Eda Capkin, Korvus Wang, Michael Fairhead, Milo Cooper, Mathew Golding, Tracy Keates, Charlotte Chinn, Peter Marples, Ali Ebrahim, Anu V. Chandran, et al.

    This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against Zika virus (ZIKV) NS2B-NS3 protease using the Creoptix Wave system. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged ZIKV NS2B-NS3 protease was captured on the streptavidin-coated chip surface. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).

  • Open Access

    Crystallisation of Zika NS5 RdRp v1

    by Anu V. Chandran, Peter Marples, Tracy Keates, Charlotte Chinn

    The main aim of this work was to identify small molecules that bind Zika NS5 RdRp (catalytic RNA-dependent RNA polymerase domain) through X-ray fragment-based screening. The Zika NS5 RDRP domain was cloned, expressed, purified, and crystallised. Suitable crystals for fragment screening were produced and optimised allowing an extensive fragment campaign to be performed. A native high-resolution structure was determined at 1.8Å and formed the basis for the fragment campaign. This has been used as the basis for work on the target for OpenBind

  • Open Access

    Assessing protein crystal tolerance of chemistry reagents for HT-crystallographic screening v2

    by Milo Cooper, Anu V. Chandran, Charlotte Chinn, Mathew Golding, Peter Marples, Ali Ebrahim, Tracy Keates, Warren Thompson, Jasmin Aschenbrenner

    This protocol describes the testing of how protein crystals survive exposure to organic chemistry reagents and solvents, with the purpose of reducing crystal attrition prior to high-throughput crystallographic screening of ligands from crude reaction mixtures containing the reagents. A step-by-step description is included, describing how to complete this process using the XChem laboratory at Diamond Light Source and the Protein Crystallisation Facility at the Research Complex at Harwell. The data analysis cut-offs, rationale, and GitHub repo for the code utilised during analysis are included. This version updates the old spreadsheet-based analysis with a Python program using pandas dataframes, XtalControl. (v.02 at time of writing) https://github.com/xchem/XtalControl

  • Open Access

    Assessing protein crystal tolerance of chemistry reagents for HT-crystallographic screening v2

    by Milo Cooper, Anu V. Chandran, Charlotte Chinn, Mathew Golding, Peter Marples, Warren Thompson, Jasmin Aschenbrenner, Ali Ebrahim, Tracy Keates

    This protocol describes the testing of how protein crystals survive exposure to organic chemistry reagents and solvents, with the purpose of reducing crystal attrition prior to high-throughput crystallographic screening of ligands from crude reaction mixtures containing the reagents. A step-by-step description is included, describing how to complete this process using the XChem laboratory at Diamond Light Source and the Protein Crystallisation Facility at the Research Complex at Harwell. The data analysis cutoffs, rationale, and the spreadsheet used during analysis are also included within the attachments.

  • Open Access

    Crystallisation of coxsackievirus A16 2A protease in space group C2 used for apo, fragment screen and follow-up compounds v1

    by Milo Cooper, Ryan Lithgo, Peter Marples, Lizbé Koekemoer, Korvus Wang, Eda Capkin, Mathew Golding, Cedric Vallee, Tracy Keates, Charlotte Chinn, et al.

    This protocol was used to grow coxsackievirus A16 (CVA16) 2A protease crystals that were used as a surrogate for enterovirus A71 (EV-A71) 2A protease in high-throughput crystallographic fragment screening and in the crystallographic screening of follow-up compounds against the target. (PDB ID of apo-structure solved using sulfur phasing: pdb_000029jc) Picornaviridae, primarily CVA16 and EV-A71, are the causative agents of paediatric hand-foot-and-mouth disease. These viruses are a target for pandemic preparedness due to the risk of higher-order complications in a large-scale outbreak. The 2A protease of the viruses is responsible for self-cleavage from the polyprotein, allowing for correct folding and assembly of capsid proteins in the final stages of viral replication. Inhibition deranges capsid folding and assembly, preventing formation of mature virions in host cells and making the protease a valuable target for antiviral activity.


  • Open Access

    Coxsackievirus A16 2A protease binding assay for compound screening using grating-coupled interferometry v1

    by Eda Capkin, Korvus Wang, Michael Fairhead, Milo Cooper, Mathew Golding, Tracy Keates, Charlotte Chinn, Peter Marples, Ali Ebrahim, Anu V. Chandran, et al.

    This protocol aims to measure kinetic parameters (ka, kd, and KD) for compounds against coxsackievirus A16 (CVA16) 2A protease using the Creoptix Wave system. CVA16 2A protease is used as a surrogate for the related enterovirus A71 (EV-A71) 2A protease in the pan-enteroviral drug discovery efforts by our collaborator, the AI-Driven Structure-Enabled Antiviral Platform (ASAP) Discovery Center, and was chosen as the target for OpenBind's first data release package. Grating-coupled interferometry (GCI) is a label-free technique to measure kinetics and affinity for different targets (proteins, small molecules, fragments, etc.) with enhanced sensitivity. Biotin-tagged CVA16 2A protease was captured on the streptavidin-coated chip surface via biotinylation. This immobilisation technique provides oriented and active protein immobilisation for binding assays and can be applied to different protein targets. Binding analysis was performed with the Repeated Analyte Pulses of Increasing Duration (RAPID) method, which involves the injection of samples at a single concentration with varied association times. Kinetic parameters were obtained from the Creoptix Wave software (v 4.5.18) and the in-house developed, open-source, Python-based tool 'SensoFit' (xchem/sensofit).


  • Open Access

    Assessing protein crystal tolerance of chemistry reagents for HT-crystallographic screening. v1

    by Milo Cooper, Anu V. Chandran, Charlotte Chinn, Mathew Golding, Peter Marples, Warren Thompson, Jasmin Aschenbrenner

    This protocol describes the testing of how protein crystals survive exposure to organic chemistry reagents and solvents, with the purpose of reducing crystal attrition prior to high-throughput crystallographic screening of ligands from crude reaction mixtures containing the reagents. A step-by-step description is included, describing how to complete this process using the XChem laboratory and Protein Crystallisation Facility at Diamond Light Source. The data analysis cutoffs, rationale, and the spreadsheet used during analysis are also included within the attachments.